Abbott Laboratories 2012 Annual Report Download - page 28

Download and view the complete annual report

Please find page 28 of the 2012 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 68

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68

26
Abbott 2012 Annual Report
Consolidated Statement of Comprehensive Income
(dollars in thousands)
Year Ended December 31 2012 2011 2010
Net Earnings $5,962,920 $ 4,728,449 $ 4,626,172
Foreign currency translation (loss) adjustments (6,826) (817,539) (2,290,256)
Net actuarial (losses) and prior service cost and credits and amortization of
net actuarial losses and prior service cost and credits,
net of taxes of $(276,076) in 2012, $(391,528) in 2011 and $(70,389) in 2010 (864,935) (510,444) (59,447)
Unrealized (losses) gains on marketable equity securities,
net of taxes of $(4,079) in 2012, $8,338 in 2011 and $61 in 2010 (7,066) 14,442 106
Net adjustments for derivative instruments designated as cash flow hedges,
net of taxes of $(29,417) in 2012, $19,857 in 2011 and $20,567 in 2010 (117,666) 83,202 128,677
Other Comprehensive (loss) (996,493) (1,230,339) (2,220,920)
Comprehensive Income $4,966,427 $ 3,498,110 $ 2,405,252
Supplemental Accumulated Other Comprehensive Income Information,
net of tax as of December 31:
Cumulative foreign currency translation loss (gain) adjustments $ 79,353 $ 72,527 $ (745,012)
Net actuarial losses and prior service cost and credits 3,595,554 2,730,619 2,220,175
Cumulative unrealized (gains) on marketable equity securities (31,363) (38,429) (23,987)
Cumulative (gains) on derivative instruments designated as cash flow hedges (49,866) (167,532) (84,330)
The accompanying notes to consolidated financial statements are an integral part of this statement.